As of January 2025 Orchestra BioMed has a market cap of $0.20 Billion USD. This makes Orchestra BioMed the world's 8217th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 18th, 2025 the market cap of Orchestra BioMed was reported to be: